MedTrace Logo

Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors

NCT02452710 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-12-12

No results posted yet for this study

Summary

This research study is evaluating the usefulness of a placebo (a tablet with no active ingredients) on fatigue in cancer survivors.

Conditions

  • Fatigue in Cancer Survivors

Interventions

OTHER

Placebo

Open-label placebo

Sponsors & Collaborators

Principal Investigators

  • Christopher Recklitis, PhD, MPH · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-02-01
Completion
2017-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02452710 on ClinicalTrials.gov